The Role of Nutraceuticals and Phytotherapy in Andrological Diseases: Tips and Tricks for Everyday Clinical Practice
Authors:
- Andrea AbramoAAAndrea Abramo
- Tommaso CeccatoTCTommaso Ceccato
- Simone BottiSBSimone Botti
- Daniele MatteviDMDaniele Mattevi
- Nicola MondainiNMNicola Mondaini
- Luca GallelliLuca Gallelli
- Truls E. Bjerklund JohansenTJTruls E. Bjerklund Johansen
- Michele RizzoMRMichele Rizzo
- Giovanni LiguoriGLGiovanni Liguori
- Alessandro ZucchiAZAlessandro Zucchi
- Luca BoeriLBLuca Boeri
Open Access
Abstract
Background/Objectives: Interest in the use of nutraceuticals and phytotherapy for the management of andrological diseases has increased markedly in recent years. In particular, growing attention has been directed toward the treatment of patients affected by erectile dysfunction (ED), male infertility, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), and induratio penis plastica (IPP). However, several areas of uncertainty remain. This narrative review aims to examine the role of nutraceuticals and phytotherapeutic agents in the management of andrological disorders. Methods: A narrative review was conducted using PubMed, Scopus, Cochrane CENTRAL, and EMBASE to identify relevant studies published over the past 25 years. Only articles published in English and involving adult populations were included in the analysis. Results: Nutraceuticals and phytotherapeutic compounds have been extensively investigated in the current literature, and certain formulations—particularly specific combinations—have been evaluated in high-quality studies. Conversely, other compounds lack sufficient scientific evidence and therefore should not be recommended in routine clinical practice. In the management of ED, the following compounds, administered either alone or in combination, have demonstrated clinically significant effects: Panax ginseng, Tribulus terrestris, L-arginine, and Withania somnifera. L-carnitine, combined with micronutrients, antioxidants, and various traditional herbal supplements, appears to be an effective therapeutic option for male infertility and subfertility. Pollen extracts play an important role in the management of CP/CPPS, while carnitine, coenzyme Q10, silymarin, bromelain, and curcumin show promising potential in the treatment of IPP. Conclusions: Nutraceuticals and phytotherapeutic agents may provide favorable outcomes in the management of andrological diseases. Although current evidence is encouraging, larger prospective studies employing standardized protocols and treatment schedules are required to confirm long-term efficacy and to optimize therapeutic strategies.Keywords
This publication has 62 references indexed in Scilit:
- ProstatitisJAMA, 2025
- Current and Future Directions of Technology in Assessment of Peyronie’s DiseaseCurrent Urology Reports, 2024
- Anti-inflammatory action of astaxanthin and its use in the treatment of various diseasesBiomedicine & Pharmacotherapy, 2022
- ESSM Position Statement on Surgical Treatment of Peyronie's DiseaseSexual Medicine, 2021
- The efficacy and safety of Serenoa repens extract for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trialWorld Journal of Urology, 2021
- Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective studyNeurourology and Urodynamics, 2020
- Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndromeCochrane Database of Systematic Reviews, 2019
- Management of Chronic Prostatitis/ Chronic Pelvic Pain SyndromeJAMA, 2011
- Herbal and complementary medicine in chronic prostatitisWorld Journal of Urology, 2003
- Peyronie Disease in Younger Men: Characteristics and Treatment ResultsJournal of Andrology, 2003